Niche DPI focus Target medical device suppliers and contract manufacturers seeking low-cost passive dry powder inhaler (DPI) solutions with consistent emitted dose and fine particle fraction performance to enhance their portfolio and meet partner dose delivery requirements.

Early-stage footprint With a small team and revenue under one million, there is an opportunity to position Manta Devices as a nimble, cost-effective partner for rapid development cycles, joint ventures, or sponsored research programs in inhalation technology.

Cambridge advantage Leverage proximity to biotech and pharma clusters in Cambridge, MA to establish collaborations with academic labs and startups for prototype validation, regulatory support, and pilot manufacturing capabilities.

Dose customization Market the ability to configure devices for large or small dose payloads, offering customers flexible DPI designs that can be tailored to specific inhalation profiles or therapeutic areas, potentially expanding into niche indications.

Technology readiness Highlight existing tech stack and digital collaboration capabilities to offer quick integration with customer data flows, test rigs, and remote monitoring, while proposing value-added services such as design for manufacturability and cost optimization.